News Conference News AHA 2025 LAAO Doesn’t Match Medical Therapy for High-risk AF Patients: CLOSURE-AF Caitlin E. Cox November 09, 2025
News Conference News AHA 2024 OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain Todd Neale November 18, 2024
News Conference News ESC 2021 Amulet IDE: LAA Occluder Performs Well Against Watchman Todd Neale August 30, 2021
News Conference News ACC 2021 Low 1-Year Stroke Risk After Commercial Watchman Use Todd Neale May 15, 2021
News Conference News ACC 2021 Occluding the LAA During Surgery Lowers Stroke Risk: LAAOS III Todd Neale May 15, 2021
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Conference News ESC 2017 European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts Shelley Wood August 27, 2017
News Conference News EuroPCR 2017 EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure Michael O'Riordan May 24, 2017
News Conference News EuroPCR 2016 LAA Closure May Provide Solution for Stroke Prevention in Patients With Prior Intracerebral Hemorrhage Yael L. Maxwell May 18, 2016
News Conference News EuroPCR 2016 EWOLUTION Confirms Safety, Efficacy for Real-World Use of Watchman, Even With No Postprocedural Drug Therapy Yael L. Maxwell May 17, 2016
News Conference News EuroPCR 2016 EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’ Shelley Wood May 16, 2016